PubMed:30836660 / 1257-1483 JSONTXT

Annnotations TAB JSON ListView MergeView

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T10","span":{"begin":0,"end":226},"obj":"Sentence"},{"id":"T10","span":{"begin":0,"end":226},"obj":"Sentence"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin-sentences

    {"project":"LitCoin-sentences","denotations":[{"id":"T10","span":{"begin":0,"end":226},"obj":"Sentence"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin-entities

    {"project":"LitCoin-entities","denotations":[{"id":"13602","span":{"begin":13,"end":16},"obj":"ChemicalEntity"},{"id":"13603","span":{"begin":140,"end":145},"obj":"GeneOrGeneProduct"},{"id":"13604","span":{"begin":147,"end":155},"obj":"GeneOrGeneProduct"},{"id":"13605","span":{"begin":157,"end":163},"obj":"GeneOrGeneProduct"},{"id":"13606","span":{"begin":165,"end":170},"obj":"GeneOrGeneProduct"},{"id":"13607","span":{"begin":172,"end":176},"obj":"GeneOrGeneProduct"},{"id":"13608","span":{"begin":215,"end":225},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A40","pred":"db_id","subj":"13602","obj":"MESH:C009172"},{"id":"A41","pred":"db_id","subj":"13603","obj":"NCBIGene:11475"},{"id":"A42","pred":"db_id","subj":"13603","obj":"NCBIGene:59"},{"id":"A43","pred":"db_id","subj":"13604","obj":"NCBIGene:22352"},{"id":"A44","pred":"db_id","subj":"13604","obj":"NCBIGene:7431"},{"id":"A45","pred":"db_id","subj":"13605","obj":"NCBIGene:21803"},{"id":"A46","pred":"db_id","subj":"13605","obj":"NCBIGene:7040"},{"id":"A47","pred":"db_id","subj":"13606","obj":"NCBIGene:20613"},{"id":"A48","pred":"db_id","subj":"13606","obj":"NCBIGene:6615"},{"id":"A49","pred":"db_id","subj":"13607","obj":"NCBIGene:20583"},{"id":"A50","pred":"db_id","subj":"13607","obj":"NCBIGene:6591"},{"id":"A51","pred":"db_id","subj":"13608","obj":"NCBIGene:12550"},{"id":"A52","pred":"db_id","subj":"13608","obj":"NCBIGene:999"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin-GeneOrGeneProduct-v0

    {"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T26","span":{"begin":13,"end":16},"obj":"GeneOrGeneProduct"},{"id":"T27","span":{"begin":142,"end":145},"obj":"GeneOrGeneProduct"},{"id":"T28","span":{"begin":147,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T29","span":{"begin":165,"end":170},"obj":"GeneOrGeneProduct"},{"id":"T30","span":{"begin":172,"end":176},"obj":"GeneOrGeneProduct"},{"id":"T31","span":{"begin":184,"end":191},"obj":"GeneOrGeneProduct"},{"id":"T32","span":{"begin":215,"end":225},"obj":"GeneOrGeneProduct"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin-GeneOrGeneProduct-v2

    {"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T12","span":{"begin":142,"end":145},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":147,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T14","span":{"begin":165,"end":170},"obj":"GeneOrGeneProduct"},{"id":"T15","span":{"begin":172,"end":176},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":215,"end":225},"obj":"GeneOrGeneProduct"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin-GeneOrGeneProduct-v3

    {"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T7","span":{"begin":142,"end":145},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":147,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T9","span":{"begin":157,"end":160},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":165,"end":170},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":172,"end":176},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":215,"end":225},"obj":"GeneOrGeneProduct"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin_Mondo_095

    {"project":"LitCoin_Mondo_095","denotations":[{"id":"T6","span":{"begin":142,"end":145},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"0019079"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin-Chemical-MeSH-CHEBI

    {"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T13","span":{"begin":13,"end":16},"obj":"ChemicalEntity"}],"attributes":[{"id":"A13","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_9009"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}

    LitCoin-training-merged

    {"project":"LitCoin-training-merged","denotations":[{"id":"T13","span":{"begin":13,"end":16},"obj":"ChemicalEntity"},{"id":"T74657","span":{"begin":215,"end":225},"obj":"GeneOrGeneProduct"},{"id":"T15367","span":{"begin":172,"end":176},"obj":"GeneOrGeneProduct"},{"id":"T55399","span":{"begin":165,"end":170},"obj":"GeneOrGeneProduct"},{"id":"T34546","span":{"begin":157,"end":160},"obj":"GeneOrGeneProduct"},{"id":"T5269","span":{"begin":147,"end":155},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":142,"end":145},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A13","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_9009"}],"text":"Furthermore, Sal administration significantly suppresses epithelial-mesenchymal transition (EMT), as evidenced by a decreased expression of α-SMA, vimentin, TGF-β1, snail, slug, and a largely restored expression of E-cadherin."}